期刊
JGH OPEN
卷 5, 期 11, 页码 1257-1265出版社
WILEY
DOI: 10.1002/jgh3.12671
关键词
angiotensin-converting enzyme 2 receptor; coronavirus disease 2019; diarrhea; gastrointestinal; liver; severe acute respiratory syndrome coronavirus 2
COVID-19 not only affects the respiratory system, but also causes gastrointestinal and liver issues, with symptoms managed through supportive therapy. Coexisting liver disease in COVID-19-infected patients can lead to liver decompensation and increased mortality.
Coronavirus disease 2019 (COVID-19) is an important health problem that has a serious adverse impact on the global economy and healthcare systems. The virus is not only involved in the respiratory system, but also causes other systemic effects as well as several gastrointestinal and liver issues. Evidence has shown direct viral invasion into the gastrointestinal tissue and supporting vascular network, causing various manifestations such as diarrhea, nausea, gastrointestinal bleeding, and abnormal liver function tests. The degree of gastrointestinal injury, especially in terms of liver involvement, is correlated with disease severity. There is no specific treatment for gastrointestinal involvement, and the symptoms can be managed with supportive therapy. Moreover, increased liver decompensation and mortality can be found in COVID-19-infected patients with coexisting liver disease. As the virus can be identified in gastrointestinal contents, endoscopic procedures during the pandemic should be carefully selected and proper protection strategies should be encouraged to prevent viral transmission.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据